Skip to main content
. Author manuscript; available in PMC: 2013 Mar 14.
Published in final edited form as: J Control Release. 2012 Aug 10;162(3):636–645. doi: 10.1016/j.jconrel.2012.07.044

Fig. 7.

Fig. 7

Therapeutic efficacy in a rat MCAO model. (a) TTC staining of brain slices (b) quantitative representation of infarct size and (c) functional outcomes assessed using a sensorimotor score. nS (native SOD1); S2p (DTSSP-cross-linked purified cl-nanozymes). Treatment was administered at the onset of reperfusion (following a 2 h ischemia) i.v. via the tail vein at a dose of 10 kU/kg and sensorimotor functions were evaluated 22 h post-reperfusion before dissecting the brains for TTC staining.